Z. Bai

LncRNA LYPLAL1-DT screening from type 2 diabetes with macrovascular complication contributes protective effects on human umbilical vein endothelial cells via regulating the miR-204-5p/SIRT1 axis

Jing Lu, X. Huo, Jianyi Lv, 2022, Cell death discovery.

BRAF Mutation as a Potential Therapeutic Target for Checkpoint Inhibitors: A Comprehensive Analysis of Immune Microenvironment in BRAF Mutated Colon Cancer

H. Pan, Jiale Gao, Jianzhen Shan, 2021, Frontiers in Cell and Developmental Biology.

Long non-coding RNA opa-interacting protein 5 antisense transcript 1 (LncRNA OIP5-AS1) promoted cisplatin resistance in nasopharyngeal carcinoma via the miR-378a-3p/nicotinamide N-methyltransferase axis

Dongli Zhang, Enhong Shi, Z. Bai, 2022, Materials Express.

A potential panel of two-long non-coding RNA signature to predict recurrence of patients with laryngeal cancer

P. Xu, Qiwei Wang, Enhong Shi, 2017, Oncotarget.

A novel lncRNA FPASL regulates fibroblast proliferation via the PI3K/AKT and MAPK signaling pathways in hypertrophic scar

Jiantuan Xiong, Sheng-chao Ma, Anning Yang, 2022, Acta biochimica et biophysica Sinica.

LncRNA FPASL suppresses fibroblast proliferation through its DNA methylation via DNMT3b in hypertrophic scar

Jiantuan Xiong, Sheng-chao Ma, Anning Yang, 2022, Acta biochimica et biophysica Sinica.

Flavonoids inhibitory effect and mechanism on laryngeal carcinoma cell cytotoxicity in AGEs/RAGE/NF-κB pathway

Dongli Zhang, Enhong Shi, Z. Bai, 2023, Materials Express.